Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $175.00 (HSBC)
- Average: $237.96
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$237.96 (+2.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$237.96 (+2.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | JPMorgan | Chris Schott | Upgrade | Overweight (Neutral) |
300.00 (210.00) |
218.43 (232.65) |
6.51% | Details |
| 10/9/2026 | CCB Int'l | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
218.43 (232.65) |
6.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
